Publications by authors named "M Birkhaeuser"
Genitourinary syndrome of menopause (GSM) has a significantly negative impact on affected women's lives. However, despite the increasing number of GSM treatment options (e.g.
View Article and Find Full Text PDFArticle Synopsis
- Research is needed for non-hormonal therapies for women who can't or choose not to use menopausal hormone therapy.
- One promising option is purified cytoplasmic pollen extract, or PureCyTonin, which has shown safety and effectiveness in alleviating menopausal symptoms in clinical studies.
- PureCyTonin works similarly to SSRIs and lacks estrogenic effects, making it potentially suitable for women with breast cancer as well.
Objectives: Two identical 12-week, randomized, double-blind, placebo-controlled, multi-arm, parallel-group Phase III studies (Study P012, NCT00560833; Study P013, NCT00535288) evaluated the efficacy and safety of esmirtazapine, an investigational medicine, for the treatment of moderate to severe vasomotor symptoms (VMS) in postmenopausal women.
Methods: Participants were randomized to placebo or esmirtazapine (2.25, 4.
Unintended pregnancy is an important public health problem worldwide. Unwanted pregnancies may end in induced abortion (legal or illegal, safe or unsafe) or in childbirth. In many parts of the world both can be life threatening.
View Article and Find Full Text PDF